Last year, the phone hacking tool maker Cellebrite announced it had suspended Serbian police as customers, after human rights researchers alleged local police and intelligence agencies used its tools ...

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Cellebrite DI (CLBT) shares are in focus after the company reported full year 2025 ...

Cellebrite DI beat estimated earnings by 7.69%, reporting an EPS of $0.14 versus an estimate of $0.13. Revenue was up $19.77 million from the same period last year. In the previous quarter, the ...

Total ARR grew 21% to $480.8 million; Revenue grew 18% to $128.8 million Net income of $21.3 million supports non-GAAP net income of $36.7 million and adjusted EBITDA of $38.3 million, 29.8% adjusted ...

Cellebrite saw 6 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Cellebrite’s stock price’s past reactions to earnings here. According to InvestingPro, Cellebrite’s ...

CEO Thomas Hogan stated that Cellebrite "closed 2025 with a solid fourth quarter that capped a year marked by meaningful strategic progress." Hogan highlighted the cementing of the Inseyets offering ...

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and ...

Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.14 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.1 per share a year ago. These figures are ...

- On Wednesday, Cellebrite (NASDAQ:CLBT) reported fourth-quarter earnings that beat analyst expectations and provided an optimistic outlook for 2026. The digital forensics company’s shares soared ...

The adjustment comes despite Cellebrite outperforming both guidance and market expectations, with Total Annual Recurring Revenue (ARR) growing 21% year-over-year, or 17% excluding the Corellium ...